Pfizer Inc (PFE) 34.93 $PFE Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 34.93 $PFE

Final Glance: Pharmaceuticals companies
AP - 2 hrs 10 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 26 mins ago
Pfizer Inc.'s (PFE) phase III study on inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia (ALL) met the first primary endpoint.
BIIB: 423.57 (+1.46), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Beat The Market Twice: 5 Top Dividend Stock Winners
at Investor's Business Daily - Wed Apr 22, 4:24PM CDT
Dividend-paying companies aren't usually known for their stock price performance, but these five Dividend Leaders are beating the market this year -- and offer big yields, too. All have bagged double-digit gains, compared with about a 6% advance for...
RAI: 76.04 (+0.43), UN: 44.06 (-0.59), WU: 20.80 (+0.10), PFE: 34.93 (+0.04), LO: 70.77 (-0.23), MSFT: 42.99 (+0.36), AAPL: 128.62 (+1.71)

Midday Glance: Pharmaceuticals companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

Capricor cell therapy candidate an Orphan Drug for Duchenne muscular dystrophy
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:56AM CDT

ROSG: 3.83 (-0.20), CAPR: 7.50 (+0.76), BMRN: 121.08 (-0.16), RNA: 18.65 (unch), PFE: 34.93 (+0.04), SRPT: 13.52 (+0.04), PTCT: 70.98 (unch), SMMT: 11.00 (-0.59)

Pfenex Inc. Shifts Focus In-House To Develop Biosimilar To Betaseron
Christopher Stoehr - at Seeking Alpha - Wed Apr 22, 11:10AM CDT

PFE: 34.93 (+0.04), PFNX: 15.12 (+0.42), HSP: 87.80 (+0.04)

Uptrend Call Working As Pfizer Stock Rises 17.5% (PFE)
Comtex SmarTrend(R) - Wed Apr 22, 9:59AM CDT
SmarTrend identified an Uptrend for Pfizer (NYSEFE) on October 30th, 2014 at $29.69. In approximately 6 months, Pfizer has returned 17.48% as of today's recent price of $34.88.
PFE: 34.93 (+0.04)

Early Glance: Pharmaceuticals companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
DoctoRx - at Seeking Alpha - Wed Apr 22, 8:28AM CDT

PFE: 34.93 (+0.04), AMGN: 169.10 (+0.64), LLY: 72.30 (+0.09), BMY: 66.60 (-0.21), SNY: 51.59 (+0.03), REGN: 472.63 (+9.41), HSP: 87.80 (+0.04), CELG: 115.54 (+0.72)

Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 6.08 (+0.21), ADXS: 22.18 (+0.10), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), BMY: 66.60 (-0.21), FPRX: 24.07 (-0.85)

Healthcare's Health Scanner: Complementary Research on Pfizer, Mylan, Teva Pharmaceutical, Bristol-Myers Squibb, and Merck & Company
PR Newswire - Wed Apr 22, 7:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MRK: 57.69 (+0.03), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), BMY: 66.60 (-0.21)

Most active New York Stock Exchange-traded stocks
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
T: 32.86 (+0.20), GE: 26.91 (+0.29), AA: 13.57 (+0.05), RF: 9.73 (+0.15), CHK: 14.41 (-0.16), PFE: 34.93 (+0.04), C: 53.10 (+0.62), HAL: 47.11 (+0.06), BAC: 15.74 (+0.24), CSX: 36.26 (+0.91), VZ: 49.57 (+0.40), RAD: 8.32 (+0.39)

Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 3:50PM CDT
Merck KGaA (MKGAF) and Pfizer Inc. (PFE) announced the commencement of a phase III study on avelumab in comparison with Taxotere for non-small cell lung cancer.
SHPG: 253.58 (+3.70), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10)

Pharma Spends Big On M&A In Q1 As Teva Pulls Trigger On Mylan
EP Vantage - Seeking Alpha - Tue Apr 21, 2:25PM CDT
The pharma and biotech buying spree showed no sign of abating in the opening months of 2015, with $69bn committed across 62 deals in the first quarter, EvaluatePharma data show. And with Teva (NYSE: TEVA ) confirming its interest in ...
AGN: 240.22 (+2.88), VRX: 206.93 (-3.92), ACT: 295.22 (+0.69), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), ABBV: 64.52 (+0.91), TEVA: 63.01 (-1.15)

Pfizer says leukemia drug met 1 goal in study
AP - Tue Apr 21, 11:06AM CDT
NEW YORK (AP) — Pfizer said Tuesday that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
PFE: 34.93 (+0.04)

Pfizer's Xalkori tagged a Breakthrough Therapy for type of lung cancer
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 9:38AM CDT

PFE: 34.93 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 197

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 212

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 22

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 169

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 161

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 163

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 122

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 293

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 219

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading

Top 5 Most Recently Viewed Articles

Planning for Long-Term Care: Key Strategies and Costs

Updated Category Personal Finance Views 226

Introduction: The Growing Need for Long-Term Care With population aging, long-term care is turning into a serious problem. Seventy percent of people turning 65 will eventually require long-term care, according to the Department of Health and Human Services and the Urban Institute. Aiding with everyday tasks like eating, dressing, and bathing is part of this kind of care....

Continue Reading
Unearth the Fear: Top Iconic Characters in Haunted Attractions

Updated Category News Views 237

Haunted attractions—yeah, they’re like the bread and butter for Halloween enthusiasts. They’re not just about spooks; they craft spine-tingling experiences that turn ordinary folks into thrill-seeking screamers. And leading this spine-chilling charge is Amber Arnett-Bequeaith, aka the Queen of Haunts. Growing up in one of the longest-standing haunted venues, she’s...

Continue Reading
Continued Drilling at Martiniere Shows Promising Gold Intercepts

Updated Category News Views 132

Wallbridge Mining's Continued Success in the Martiniere Gold Project Wallbridge Mining Company Limited (TSX: WM, OTCQB:WLBMF) has recently announced the results from seven additional drill holes at its Martiniere gold project. With promising high-grade gold intercepts identified in these latest results, the company’s commitment to exploring and expanding the mineral...

Continue Reading
Baijiayun Group Ltd Expands Board with New Independent Members

Updated Category News Views 176

Baijiayun Group Ltd Expands Board with New Independent Members Baijiayun Group Ltd, a prominent player in AI video solutions, is undergoing significant changes in its board of directors. This shift involves the resignation of experienced independent directors and the appointment of two highly qualified new members. Resignation of Board Members Recently, Mr. Erlu Lin and...

Continue Reading
Join the Fight: Investors Unite for Skyworks Solutions Claims

Updated Category News Views 169

Investors Invited to Take Action Against Skyworks Solutions Levi & Korsinsky, LLP is reaching out to investors of Skyworks Solutions, Inc. (NASDAQ: SWKS), inviting them to join a class action securities lawsuit aimed at recovering financial losses. This legal initiative highlights the importance of standing together when adverse events affect shareholder value....

Continue Reading